SCANDION Financial Statements From 2010 to 2024
| 8VY Stock | EUR 0.01 0.0002 3.33% |
Check SCANDION ONC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SCANDION ONC's main balance sheet or income statement drivers, such as , as well as many indicators such as . SCANDION financial statements analysis is a perfect complement when working with SCANDION ONC Valuation or Volatility modules.
SCANDION |
SCANDION ONC DK 0735 Company Shares Owned By Insiders Analysis
SCANDION ONC's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current SCANDION ONC Shares Owned By Insiders | 1.82 % |
Most of SCANDION ONC's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SCANDION ONC DK 0735 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 1.816% of SCANDION ONC DK 0735 are shares owned by insiders. This is 88.04% lower than that of the Healthcare sector and 87.19% lower than that of the Biotechnology industry. The shares owned by insiders for all Germany stocks is 82.0% higher than that of the company.
SCANDION ONC DK Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SCANDION ONC's current stock value. Our valuation model uses many indicators to compare SCANDION ONC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SCANDION ONC competition to find correlations between indicators driving SCANDION ONC's intrinsic value. More Info.SCANDION ONC DK 0735 is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SCANDION ONC's earnings, one of the primary drivers of an investment's value.About SCANDION ONC Financial Statements
SCANDION ONC stakeholders use historical fundamental indicators, such as SCANDION ONC's revenue or net income, to determine how well the company is positioned to perform in the future. Although SCANDION ONC investors may analyze each financial statement separately, they are all interrelated. For example, changes in SCANDION ONC's assets and liabilities are reflected in the revenues and expenses on SCANDION ONC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in SCANDION ONC DK 0735. Please read more on our technical analysis and fundamental analysis pages.
Scandion Oncology AS, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. The company was founded in 2017 and is based in Copenhagen, Denmark. SCANDION ONC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.
Currently Active Assets on Macroaxis
Other Information on Investing in SCANDION Stock
SCANDION ONC financial ratios help investors to determine whether SCANDION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDION with respect to the benefits of owning SCANDION ONC security.